Teledermatology eases disease management for young acne patients.
An exploration of the feasibility of using laser technology to detect changes in microvasculature during the acne lesion healing progress and to introduce a microvasculature-based biomarker in evaluating the treatment and grading of acne.
Findings could pave the way to more effective treatments for drug-resistant infections caused by MRSA
A phase 3 clinical program is under way to further evaluate the efficacy and safety of Cimzia (certolizumab pegol, UCB) in adult patients with moderate to severe chronic plaque psoriasis.
A Canadian study suggests that Epiduo Gel used in combination with the oral antibiotic doxycycline, compares favorably with oral isotretinoin in the treatment of severe nodular acne. Learn more
The Food and Drug Administration has approved Bellafill (Suneva Medical) for the treatment of acne scars. Learn more on the approval
The Food and Drug Administration has approved Onexton Gel (clindamycin phosphate and benzoyl peroxide 1.2 percent/3.75 percent, Valeant Pharmaceuticals) for the once-daily treatment of comedonal and inflammatory acne in patients 12 and older.
New results from a phase-3 study demonstrating the effect of Humira (adalimumab, AbbVie) in treating moderate-to-severe hidradenitis suppurativa (HS) may lead to worldwide regulatory filings for expanded use of the drug.
Though it’s known that oral contraceptive pills (OCPs) and systemic antibiotics are both effective in managing acne, there’s been precious little research comparing the two therapies head-to-head — until now.
The Food and Drug Administration has issued a warning that some common over-the-counter acne treatments can cause severe irritation or even life-threatening allergic reactions.